Yucheng H. Wu
No. 37, Guoxue Alley
Chengdu, 610041, China
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Estimated small dense low-density lipoprotein-cholesterol and the risk of kidney and cardiovascular outcomes in diabetic kidney disease.
Journal: Renal failure
Published: July 02, 2024
Impact of non-alcoholic fatty liver disease and fibrosis on mortality and kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A multi-cohort longitudinal study.
Journal: Diabetes, obesity & metabolism
Published: February 26, 2024
Remnant cholesterol and the risk of diabetic nephropathy progression to end-stage kidney disease in patients with type 2 diabetes mellitus: a longitudinal cohort study.
Journal: Endocrine
Published: February 24, 2024
GLP-1 receptor agonist, liraglutide, protects podocytes from apoptosis in diabetic nephropathy by promoting white fat browning.
Journal: Biochemical and biophysical research communications
Published: March 11, 2023
The association of plasma NT-proBNP level and progression of diabetic kidney disease.
Journal: Renal failure
Published: February 23, 2023
Whether Renal Pathology Is an Independent Predictor for End-Stage Renal Disease in Diabetic Kidney Disease Patients with Nephrotic Range Proteinuria: A Biopsy-Based Study.
Journal: Journal of clinical medicine
Published: November 21, 2022
Metabolic phenotypes and risk of end-stage kidney disease in patients with type 2 diabetes.
Journal: Frontiers in endocrinology
Published: November 20, 2022
Efficacy and safety of drugs for people with type 2 diabetes mellitus and chronic kidney disease on kidney and cardiovascular outcomes: A systematic review and network meta-analysis of randomized controlled trials.
Journal: Diabetes research and clinical practice
Published: October 27, 2022
Intravitreal vascular endothelial growth factor inhibitors did not increase the risk of end-stage renal disease in patients with biopsy-proven diabetic kidney disease based on matched study.
Journal: Frontiers in pharmacology
Published: October 22, 2022
Lower bile acids as an independent risk factor for renal outcomes in patients with type 2 diabetes mellitus and biopsy-proven diabetic kidney disease.
Journal: Frontiers in endocrinology
Published: August 24, 2022
Metabolic-associated fatty liver disease increases the risk of end-stage renal disease in patients with biopsy-confirmed diabetic nephropathy: a propensity-matched cohort study.
Journal: Acta diabetologica
Published: August 08, 2022
Last Updated: 09/26/2026